NCT00548938View on ClinicalTrials.gov

Gliadel Wafer, Temozolomide and Radiation Therapy for Newly Diagnosed GBM

PHASE2TerminatedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2010

Conditions
Glioblastoma MultiformeHigh-Grade Glioma
Interventions
DRUG

Gliadel wafer

Implanted at surgery

DRUG

Temozolomide

During External Beam Radiation

RADIATION

External Beam Radiation Therapy

60 Gy

Trial Locations (1)

38104

Methodist University Hospital, Memphis

Sponsors
All Listed Sponsors
lead

Methodist Healthcare

OTHER

NCT00548938 - Gliadel Wafer, Temozolomide and Radiation Therapy for Newly Diagnosed GBM | Biotech Hunter | Biotech Hunter